A single institution's experience with bevacizumab and cytoxic chemotherapy in progressive malignant glioma

被引：1
|
作者：
Mayer, T. M.
Lacy, J.
Baehring, J.
机构：
[1] Yale New Haven Med Ctr, New Haven, CT 06504 USA
[2] Yale Canc Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.13010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13010
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma
    Mayer, Tina
    Lacy, Jill
    Baehring, Joachim
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 455 - 459
  • [2] BEVACIZUMAB IN RECURRENT MALIGNANT GLIOMA, A SINGLE INSTITUTION EXPERIENCE
    Cunha, J.
    Almeida, M.
    Couto, E.
    Amorim, J.
    Nabico, R.
    NEURO-ONCOLOGY, 2017, 19 : 71 - 71
  • [3] Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
    Mesti, Tanja
    Moltara, Maja Ebert
    Boc, Marko
    Rebersek, Martina
    Ocvirk, Janja
    RADIOLOGY AND ONCOLOGY, 2015, 49 (01) : 80 - 85
  • [4] Bevacizumab for recurrent malignant glioma - a single institution experience with 120 patients
    Platten, M.
    Wick, A.
    Lemke, D.
    Loew, S.
    Schemmer, D.
    Wick, W.
    ONKOLOGIE, 2010, 33 : 57 - 57
  • [5] CHEMOTHERAPY FOR MALIGNANT GLIOMA PATIENTS: A SINGLE INSTITUTION EXPERIENCE WITH 57 CASES
    Zhang, Jun-ping
    Chen, Zhong-ping
    NEURO-ONCOLOGY, 2011, 13 : 47 - 47
  • [6] MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA
    Carrillo, Jose
    Wagle, Naveed
    Carrillo, Jose
    Juntila, Joanna
    Nguyen, Minhdan
    Truong, Judy
    Landa, Eve
    Curry, Erin
    Juarez, Tiffany
    Kesari, Santosh
    NEURO-ONCOLOGY, 2021, 23 : 76 - 76
  • [7] Bevacizumab and chemotherapy for recurrent glioblastoma A single-institution experience
    Nghiemphu, P. L.
    Liu, W.
    Lee, Y.
    Than, T.
    Graham, C.
    Lai, A.
    Green, R. M.
    Pope, W. B.
    Liau, L. M.
    Mischel, P. S.
    Nelson, S. F.
    Elashoff, R.
    Cloughesy, T. F.
    NEUROLOGY, 2009, 72 (14) : 1217 - 1222
  • [8] Chemotherapy for malignant pleural mesothelioma - a single institution experience
    Arif, S. S.
    Linnane, S. J.
    Duckers, J.
    Lester, J. F.
    LUNG CANCER, 2009, 63 : S27 - S27
  • [9] VINORELBINE IN PROGRESSIVE UNRESECTABLE LOW GRADE GLIOMA: EXPERIENCE OF A SINGLE INSTITUTION
    Cappellano, A. M.
    Cavalheiro, S.
    Bergamo, M.
    Carmona, P.
    Soares, M. F. F.
    Tostes, V. S.
    Seixas, M. T.
    da Silva, N. S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II20 - II20
  • [10] Single Agent Bevacizumab for Recurrent Malignant Glioma
    Cadoo, K.
    O'Brien, M.
    Grogan, L.
    Breathnach, O.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S588 - S588
12345